Thyroid cell proliferation in Graves' disease. Use of MIB-1 monoclonal antibody.
D000293:Adolescent; D000328:Adult; D000974:Antibodies, Antinuclear / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000378:metabolism; D013956:Antithyroid Agents / Q000494:pharmacology; D044963:Biopsy, Fine-Needle; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002648:Child; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000276:immunology / Q000378:metabolism; D008297:Male; D008713:Methimazole / Q000494:pharmacology; D008875:Middle Aged; D011237:Predictive Value of Tests; D011441:Propylthiouracil / Q000494:pharmacology; D015203:Reproducibility of Results; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*
D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal; D013956:Antithyroid Agents; D019394:Ki-67 Antigen; C440408:MIB-1 antibody; D008713:Methimazole; D011441:Propylthiouracil